Long-term combination therapy of ustekinumab and dapsone in a patient with psoriasis and dermatitis herpetiformis Duhring.
Spyridon
S
Gkalpakiotis
Petr
P
Arenberger
Eva
E
Sticova
Petra
P
Sefrnova
Monika
M
Arenbergerova
D000890:Anti-Infective Agents / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D003622:Dapsone / Q000627:therapeutic use*; D003874:Dermatitis Herpetiformis / Q000150:complications / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000150:complications / Q000188:drug therapy*; D013997:Time Factors; D000069549:Ustekinumab
D000890:Anti-Infective Agents; D061067:Antibodies, Monoclonal, Humanized; D007155:Immunologic Factors; D003622:Dapsone; D000069549:Ustekinumab